Viewing Study NCT01309633


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2025-12-30 @ 3:26 PM
Study NCT ID: NCT01309633
Status: COMPLETED
Last Update Posted: 2019-07-22
First Post: 2011-03-03
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)
Sponsor: National University Hospital, Singapore
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2011-09-02
Start Date Type: ACTUAL
Primary Completion Date: 2019-03-11
Primary Completion Date Type: ACTUAL
Completion Date: 2019-03-11
Completion Date Type: ACTUAL
First Submit Date: 2011-03-03
First Submit QC Date: None
Study First Post Date: 2011-03-07
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-07-19
Last Update Post Date: 2019-07-22
Last Update Post Date Type: ACTUAL